[1] J A LAWSON. Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.[J]. The Journal of Biological Chemistry, 1998, 273 45: 29295-29301. DOI:
10.1074/jbc.273.45.29295[2] J D MORROW. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1990, 87 23: 9383-9387. DOI:
10.1073/pnas.87.23.9383[3] RUSSELL J. WAUGH . Identification and Relative Quantitation of F2-Isoprostane Regioisomers Formed in vivo in the Rat[J]. Free Radical Biology and Medicine, 1997, 23 6: Pages 943-954. DOI:
10.1016/s0891-5849(97)00133-0[4] MUSTAFA ADIYAMAN . Total Synthesis of 17,17,18,18-d4-iPF2α-VI and Quantification of iPF2α-VI in Human Urine by Gas Chromatography/Mass Spectrometry[J]. Analytical biochemistry, 1998, 262 1: Pages 45-56. DOI:
10.1006/abio.1998.2767[5] D PRATICÒ. IPF2alpha-I: an index of lipid peroxidation in humans.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95 7: 3449-3454. DOI:
10.1073/pnas.95.7.3449[6] MIRANDA VAN ECK. Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL.[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2007, 27 11: 2413-2419. DOI:
10.1161/atvbaha.107.145474[7] CONCETTA GARDI. F2-isoprostane receptors on hepatic stellate cells[J]. Laboratory Investigation, 2007, 88 2: 124-131. DOI:
10.1038/labinvest.3700712